News Interim report for the first nine months of 2022 Please read the full announcement in PDF Attachment 2022_27_Q32022_CompanyAnnouncement Continue Reading Previous Addex Therapeutics to Report Third Quarter 2022 Financial Results and Host Conference Call on November 11, 2022Next APEIRON Respiratory Therapies announces positive results from Phase I trial of inhaled APN01 Related Stories News Alpix Shares Early Beta Insights on AI-Assisted Trading and On-Chain Perpetuals Platform News Heavyweight Endorsement from Top-tier Cornerstone Investors! Sigenergy (06656.HK) Launches IPO: Led by Temasek and Goldman Sachs, the AI Energy Storage Leader Ignites Hong Kong’s New Stock Frenzy News Shoucheng Holdings (0697.HK) Combines Dividends and Share Buybacks in Tandem, Returning Approximately HK$6.877 Billion to Shareholders Over Eight Years News Formerra Announces Global Price Increase News U.S. Polo Assn. and ESPN Champion the Iconic USPA Gold Cup at the USPA National Polo Center, Hosted by Legendary Commentator Chris Fowler News Lithosphere Deploys MultX to Enable Atomic Cross-Chain Execution on Makalu